Trinity Biotech falls below Nasdaq public float requirement
Source: SeekingAlpha
2026-02-20 17:13:25 ET
More on Trinity Biotech
- Trinity Biotech rises on order for 9M TrinScreen HIV tests
- Seeking Alpha’s Quant Rating on Trinity Biotech
- Financial information for Trinity Biotech
Read the full article on Seeking Alpha
For further details see:
Trinity Biotech falls below Nasdaq public float requirement
Trinity Biotech plc
NASDAQ: TRIB
TRIB Trading
-4.61% G/L:
$0.7145 Last:
62,952 Volume:
$0.69 Open:
TRIB Latest News
February 25, 2026 09:00:00 am
Trinity Biotech Secures $25 Million Financing Commitment to Support Growth Initiatives
February 20, 2026 05:00:00 pm
Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares
TRIB Stock Data
$17,567,131
17,007,692
5.8%
31
N/A
Medical Diagnostics & Screening
Healthcare
IE
Bray
